Ran Bi
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
Papers in
-
- Ferroptosis and cancer prognosis 4
- Chronic Obstructive Pulmonary Disease (COPD) Research 3
-
- Andrographolide Research and Applications 3
- Co-authors
- Yanting LinXinghua GaoQiuhua CaoFei QuanChongxiu YueYong YangHongbao YangYue Wang
- Journals
- European Journal of Pharmacology (3 papers)Expert Review of Respiratory Medicine (2 papers)Ocean Engineering (2 papers)Journal of Functional Foods (2 papers)Scientific Reports (1 paper)
- Partner nations
- ChinaUnited StatesArgentina
In The Last Decade
Ran Bi
42 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Cancer Research 536
- Pulmonary and Respiratory Medicine 708
- Nephrology 102
- Molecular Biology 800
- Nutrition and Dietetics 111
Countries citing papers authored by Ran Bi
This map shows the geographic impact of Ran Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Bi more than expected).
Fields of papers citing papers by Ran Bi
This network shows the impact of papers produced by Ran Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Bi. The network helps show where Ran Bi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ran Bi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 7 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 11 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 16 | |
| 11 | 2021 | 15 | |
| 12 | Quercetin alleviates acute kidney injury by inhibiting ferroptosis Hit paper breakdown → | 2020 | 464 |
| 13 | 2019 | 16 | |
| 14 | 2019 | 8 | |
| 15 | 2019 | 48 | |
| 16 | 2018 | 15 | |
| 17 | 2018 | 69 | |
| 18 | [Analysis of clinicopathological features and risk factors for postoperative complications in the elderly gastric cancer patients]. | 2016 | 1 |
| 19 | 2015 | 10 | |
| 20 | 2012 | 13 |
About Ran Bi
Ran Bi is a scholar working on Pulmonary and Respiratory Medicine, Complementary and alternative medicine, Neurology, Cancer Research and Oncology, having authored 46 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (4 papers), Cancer, Lipids, and Metabolism (4 papers), Andrographolide Research and Applications (3 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (3 papers), Cancer-related Molecular Pathways (3 papers), Asthma and respiratory diseases (3 papers), Identification and Quantification in Food (2 papers) and Neuroinflammation and Neurodegeneration Mechanisms (2 papers). The work is most often cited by research in Cancer Research (536 citations), Pulmonary and Respiratory Medicine (708 citations), Nephrology (102 citations), Molecular Biology (800 citations) and Nutrition and Dietetics (111 citations). Ran Bi has collaborated with scholars based in China, United States and Argentina. Frequent co-authors include Yanting Lin, Xinghua Gao, Qiuhua Cao, Fei Quan, Chongxiu Yue, Yong Yang, Hongbao Yang, Yue Wang, Peng Liu and Dayong Zhang. Their work appears in journals such as European Journal of Pharmacology, Expert Review of Respiratory Medicine, Ocean Engineering, Journal of Functional Foods and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.